Culture results of heart valves resected because of streptococcal endocarditis: Insights into duration of treatment to achieve valve sterilization

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 2, 2005, Pages 234-239

  Upton, Arlo ^a   Drinković, Dragana ^a   Pottumarthy, Sudha ^a   West, Teena ^a   Morris, Arthur J ^a,b  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^b Microbiology Laboratory   (New Zealand)

Author keywords

haemolytic streptococci; haemolytic streptococci; Streptococcus anginosus; Streptococcus pneumoniae; Surgery

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; GENTAMICIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HEART VALVE SURGERY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; RETROSPECTIVE STUDY; REVIEW; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

ADULT; ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HEART VALVES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STERILIZATION; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS PNEUMONIAE;

EID: 14744294268     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh527     Document Type: Review

References (31)

1. Working Party of the British Society for Antimicrobial Chemotherapy. (1998). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207-10.
2. Wilson, W., Karchmer, A., Dajani, A. et al. (1995). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterocooci, staphylococci, and HACEK microorganisms. Journal of the American Medical Association 274, 1706-13.
3. Lefort, A., Lotholary, O., Casassus, P. et al. (2002). Comparison between adult endocarditis due to β-haemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri. Archives of Internal Medicine 162, 2450-6.
4. Rollan, M., San Roman, J., Vilacosta, I. et al. (2003). Clinical profile of Streptococcus agalactiae native valve endocarditis. American Heart Journal 146, 1095-8.
5. Sambola, A., Miro, J., Tornos, M. et al. (2002). Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clinical Infectious Diseases 34, 1576-84.
6. Woo, P., Tse, H., Chan, K. et al. (2004). ' Streptococcus milleri' endocarditis caused by Streptococcus anginosus. Diagnostic Microbiology and Infectious Disease 48, 81-8.
7. Morris, A., Drinkovic, D., Pottumarthy, S. et al. (2003). Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clinical Infectious Diseases 36, 697-704.
8. Drinković, D., Morris, A., Pottumarthy, S. et al. (2003). Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. Journal of Antimicrobial Chemotherapy 52, 820-5.
9. National Committee for Clinical Laboratory Standards. (2004). Performance Standards for Antimicrobial Susceptibility Testing. Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA.
10. Li, J., Sexton, D., Mick, N. et al. (2000). Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clinical Infectious Diseases 30, 633-8.
11. Le, T. & Bayer, A. (2003). Combination antibiotic therapy for infective endocarditis. Clinical Infectious Diseases 36, 615-21.
12. Bayer, A. & Scheld, W. (2000). Endocarditis and intravascular infections. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th edn (Mandell, G., Bennett, J. & Dolin, R., Eds), pp. 857-902. Churchill Livingston, Philadelphia, PA, USA.
13. Wilson, W., Thompson, R., Wilkowske, C. et al. (1981). Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. Journal of the American Medical Association 245, 360-3.
14. Burkert, T. & Watanakunakorn C. (1991). Group A streptococcus endocarditis: report of five cases and review of literature. Journal of Infection 23, 307-16.
15. Ramirez, C., Naraqi, S. & McCulley, D. (1984). Group A β-haemolytic streptococcus endocarditis. American Heart Journal 108, 1383-6.
16. Baddour, L. (1998). Infective endocarditis caused by β-haemolytic streptococci. Clinical Infectious Diseases 26, 66-71.
17. Roberts, R., Krieger, A., Schiller, N. et al. (1979). Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci. Reviews of Infectious Diseases 1, 955-66.
18. Gephart, J. & Washington, J. (1982). Antimicrobial susceptibilities of nutritionally variant streptococci. Journal of Infectious Diseases 146, 536-9.
19. Levine, J., Hanna, B. & Pollock, A. (1983). Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy. American Journal of Medical Science 286, 31-6.
20. 6-dependent viridans group Streptococcus. Paediatrics 66, 309-12.
21. Stein, D. & Nelson, K. (1987). Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Reviews of Infectious Diseases 9, 908-16.
22. Holloway, Y. & Dankert, J. (1982). Penicillin tolerance in nutritionally variant streptococci. Antimicrobial Agents and Chemotherapy 22, 1073-5.
23. Bantar, C., Canigia, L., Relloso, S. et al. (1996). Species belonging to the 'Streptococcus milleri' group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. Journal of Clinical Microbiology 34, 2020-2.
24. Tracy, M., Wanahita, A., Shuhatovich, Y. et al. (2001). Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrobial Agents and Chemotherapy 45, 1511-4.
25. Murray, H., Gross, K., Masure, H. et al. (1978). Serious infections caused by Streptococcus milleri. American Journal of Medicine 64, 759-64.
26. Mylonakis, E. & Calderwood, S. (2001). Infective endocarditis in adults. New England Journal of Medicine 345, 1318-30.
27. Singh, K., Morris, A., Lang, S. et al. (1988). Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. New Zealand Medical Journal 101, 813-6.
28. Casariego, E., Rodriguez, A., Corredoira, J. et al. (1996). Prospective study of Streptococcus milleri bacteraemia. European Journal of Clinical Microbiology and Infectious Diseases 15, 194-200.
29. Aronin, I., Mukhejee, S., West, J. et al. (1998). Review of pneumococcal endocarditis in adults in the penicillin era. Clinical Infectious Diseases 26, 165-71.
30. Martinez, E., Miro, J., Almirante, B. et al. (2002). Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clinical Infectious Diseases 35, 130-9.
31. Lefort, A., Mainardi, J., Selton-Suty, C. et al. (2000). Streptococcus pneumoniae endocarditis in adults: a multicenter study in France in the era of penicillin resistance (1991-1998). Medicine 79, 327-37.